Analysis of the native murine bone morphogenetic protein serine threonine kinase type I receptor (ALK-3)

Journal of Cellular Physiology

Volumn 168, Issue 2, 1996, Pages 453-461

  Wu, Xiying ^a   Robinson, Claudius E ^a,b   Fong, Hon WA ^a,c,d   Gimble, Jeffrey M ^a,b,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d Women's Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; PROTEIN SERINE THREONINE KINASE; RECEPTOR PROTEIN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; MYOBLAST; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; STROMA CELL;

ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; BONE MARROW; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL MEMBRANE; CLONING, MOLECULAR; MANNOSYL-GLYCOPROTEIN ENDO-BETA-N-ACETYLGLUCOSAMINIDASE; MICE; MOLECULAR SEQUENCE DATA; MUSCLE FIBERS; PHENOTYPE; PRECIPITIN TESTS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RECEPTORS, GROWTH FACTOR; STROMAL CELLS; URIDINE MONOPHOSPHATE;

EID: 0029737005     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199608)168:2<453::AID-JCP24>3.0.CO;2-2     Document Type: Article

References (67)

1. Attisano, L., Wrana, J.L., Lopez-Casillas, F., and Massague, J. (1994) TGF-β receptors and actions. Biochim. Biophys. Acta., 1222:71-80.
2. Aviv, H., and Leder, P. (1972) Purification of biologically active globin messenger RNA by chromatography on oligothymic acid-cellulose. Proc. Natl. Acad. Sci. U.S.A., 69:1408-1412.
3. Baarends, W.M., van Helmond, M.J.L., Post, M., van der Schoot, P.J.C.M., Hoogerbrugge, J.W., de Winter, J.P., Uilenbroek, J.T.J., Karels, B., Wilming, L.G., Meijers, J.H.C., Themmen, A.P.N., and Grootegoed, J.A. (1994) A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Muellerian duct. Development, 120:189-197.
4. Blau, H., Pavlath, G.K., Hardeman, E.C., Chiu, C.-P., Silberstein, L., Webster, S.G., Miller, S.C., and Webster, C. (1985) Plasticity of the differentiated state. Science, 230:758-766.
5. Centrella, M., Horowitz, M.C., and Wozney, J.M. (1994) Transforming growth factor-β gene family members and bone. Endocrinol. Rev., 15:27-37.
6. 1. J. Bone Min. Res., 6:1387-1393.
7. Chomczynski, P., and Sacchi, N. (1987) Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162:156-159.
8. Church, G., and Gilbert, W. (1984) Genomic sequencing. Proc. Natl. Acad. Sci. U.S.A., 81:1991-1995.
9. Derynck, R. (1994) TGF-β-receptor-mediated signalling. Trends Biol. Sci., 19:548-553.
10. Dewulf, N., Verschueren, K., Lonnoy, O., Moren, A., Grimsby, S., Vande Spiegle, K., Miyazono, K., Huylesbroeck, D., and ten Dijke, P. (1995) Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology, 136:2652-2663.
11. ten Dijke, P., Ichijo, H., Franzen, P., Schulz, P., Saras, J., Toyoshima, H., Heldin, C.-H., and Miyazono, K. (1993) Activin receptor-like kinases: A novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene, 8:2879-2887.
12. ten Dijke, P., Franzen, P., Yamashita, H., Ichijo, H., Heldin, C.-H., and Miyazono, K. (1994a) Serine/threonine kinase receptors. Prog. Growth Factor Res., 5:55-72.
13. ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K., and Heldin, C.-H. (1994b) Characterization of type I receptors for transforming growth factor-β and activin. Science, 264:101-104.
14. ten Dijke, P., Yamashita, H., Sampath, T.K., Reddi, A.H., Estevez, M., Riddle, D.L., Ichijo, H., Heldin, C.-H., and Miyazono, K. (1994c) Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem., 269:16985-16988.
15. Dorheim, M.A., Sullivan, M., Dandapani, V., Wu, X., Hudson, J., Segarini, P.R., Rosen, P.R., Aulthouse, A.L., and Gimble, J.M. (1993) Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells. J. Cell. Physiol., 154:317-328.
16. Ebner, R., Chen, R.-H., Shum, L., Lawler, S., Zioncheck, T.F., Lee, A., Lopez, A.R., and Derynck, R. (1993) Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science, 260:1344-1348.
17. Estevez, M., Attisano, L., Wrana, J.L., Albert, P.S., Massague, J., and Riddle, D.L. (1993) The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature, 365:644-649.
18. Feinberg, A.P., and Vogelstein, B. (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132:6-13.
19. Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C.-H., and Miyazono, K. (1993) Cloning of a TGFβ type I receptor that forms a heterdimeric complex with the TGFβ type II receptor. Cell, 75:681-692.
20. Frolik, C.A., Wakefield, L.M., Smith, D.M., and Sporn, M.B. (1984) Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts. J. Biol. Chem., 259:10995-11000.
21. Gazit, D., Ebner, R., Kahn, A.J., and Derynck, R. (1993) Modulation of expression and cell surface binding of members of the transforming growth factor-β superfamily during retinoic acid induced osteoblastic differentiation of multipotential mesenchymal cells. Mol. Endocrinol., 7:189-198.
22. Gimble, J.M., Dorheim, M.A., Cheng, Q., Medina, K., Wang, C.S., Jones, R., Koren, E., Pietrangeli, C., and Kincade, P.W. (1990) Adipogenesis in a murine bone marrow stromal cell line capable of supporting B lineage lymphocyte growth and proliferation: Biochemical and molecular characterization. Eur. J. Immunol., 20:379-387.
23. Gimble, J.M., Morgan, C., Kelly, K., Wu, X., Dandapani, V., Wang, C.-S., and Rosen, V. (1995) Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J. Cell. Biochem. (in press).
24. Graff, J.M., Thies, R.S., Song, J.J., Celeste, A.J., and Melton, D.A. (1994) Studies with a xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo. Cell, 79:169-179.
25. 1 on lymphohematopoiesis in long-term bone marrow cultures. Blood, 74:1711-1717.
26. He, W.W., Gustafson, M.L., Hirobe, S., and Donohoe, P.K. (1993) Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-β type II receptor family. Dev. Dynamics, 196:133-142.
27. Ignotz, R.A., and Massague, J. (1985) Type β transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc. Natl. Acad. Sci. U.S.A., 82:8350-8354.
28. Iwasaki, S., Tsuruoka, N., Hattori, A., Sato, M., Tsujimoto, M., and Kohno, M. (1995) Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2. J. Biol. Chem., 270:5476-5482.
29. Jensenius, J.C., Andersen, I., Hau, J., Crone, M., and Koch, C. (1981) Eggs: Conveniently packaged antibodies. Methods for purification of yolk IgG. J. Immunol. Methods, 46:63-68.
30. Johansson, B.M., and Wiles, M.V. (1995) Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hemopoietic development. Mol. Cell. Biol., 15:141-151.
31. Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikedu, T., Rosen, V., Wozney, J.M., Fujisawa-Sehara, A., and Suda, T. (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol., 127:1755-1766.
32. Kawabata, M., Chytil, A., and Moses, H.L. (1995) Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-β receptor. J. Biol. Chem., 270:5625-5630.
33. Kehrl, J.H., Roberts, A.B., Wakefield, L.M., Jakowlew, S., Sporn, M.B., and Fauci, A.S. (1986) Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J. Immunol., 137:3855-3860.
34. Koenig, B.B., Cook, J.S., Wolsing, D.H., Ting, J., Tiesman, J.P., Correa, P.E., Olson, C.A., Pecquet, A.L., Ventura, F., Grant, R.A., Chen, G.-X., Wrana, J.L., Massague, J., and Rosenbaum, J.S. (1994) Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol. Cell. Biol., 14:5961-5974.
35. 4. Nature, 227:680-685.
36. Liu, F., Ventura, F., Doody, J., and Massague, J. (1995) Human type II receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs. Mol. Cell. Biol., 15:3479-3486.
37. Lu, Y.A., Clavigo, P., Galatino, M., Shen, Z.Y., Liu, W., and Tam, J.P. (1991) Chemically unambiguous peptide immunogen: Preparation, orientation and antigenicity of purified peptide conjugated to multiple antigen peptide system. Mol. Immunol., 28:623-630.
38. 1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro. Exp. Cell Res., 210:224-229.
39. Maeno, M., Ong, R.C., Suzuki, A., Ueno, N., and Kung, H.-F. (1994) A truncated bone morphogenetic protein 4 receptor alters the fate of ventral mesoderm to dorsal mesoderm: Roles of animal pole tissue in the development of ventral mesoderm. Proc. Natl. Acad. Sci. U.S.A., 91:10260-10264.
40. Massague, J., Cheifetz, S., Endo, T., and Nadal-Ginard, B. (1986) Type β transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. U.S.A., 83:8206-8210.
41. Mathews, L.S., and Vale, W.W. (1991) Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell, 65:973-982.
42. Matsuzaki, K, Yu, J., Wang, F., McKeehan, W.L., Krummen, L., and Kan, M. (1993) A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor-β, or bone morphogenetic protein. J. Biol. Chem., 268:12719-12723.
43. Mizushima, S., and Nagata, S. (1990) pEF-BOX, a powerful mammalian expression vector. Nucleic Acids Res., 18:5322.
44. Murray, S.S., Murray, E.J.B., Glackin, C.A., and Urist, M.R. (1993) Bone morphogenetic protein inhibits differentiation and affects expression of helix-loop-helix regulatory molecules in myoblastic cells. J. Cell. Biochem., 53:51-60.
45. Nohno, T., Ishikawa, T., Saito, T., Hosokawa, K., Noji, S., Wolsing, D., and Rosenbaum, J.S. (1995) Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential deteromeric complexes with bone morphogenetic protein type I receptors. J. Biol. Chem., 270:22522-22526.
46. Ohta, M., Greenberger, J.S., Ankelsaria, P., Bassols, A., and Massague, J. (1987) Two forms of transforming growth factor-β distinguished by multipotential hematopoietic progenitor cells. Nature, 329:539-541.
47. Olson, E.N., Sternberg, E., Hu, J.S., Spizz, G., and Wilcox, C. (1986) Regulation of myogenic differentiation by type β transforming growth factor. J. Cell Biol., 103:1799-1805.
48. Paralkar, V.M., Hammonds, R.G., and Reddi, A.H. (1991) Identification and characterization of cellular binding proteins (receptors) for recombinant human bone morphogenetic protein 2B, an initiator of bone differentiation cascade. Proc. Natl. Acad. Sci. U.S.A., 88:3397-3401.
49. Pietrangeli, C.E., Hayashi, S.I., and Kincade, P.W. (1988) Stromal cell lines which support lymphocyte growth: Characterization, sensitivity to radiation and responsiveness to growth factors. Eur. J. Immunol., 18:863-872.
50. Posnett, D.N., McGrath, H., and Tam, J.P. (1988) A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor β-chain. J. Biol. Chem., 263:1719-1725.
51. Reddi, H., and Huggins, C.B. (1975) Formation of bone marrow in fibroblast-transformation ossicles. Proc. Natl. Acad. Sci. U.S.A., 72:2212-2216.
52. Sanger, F., Nicklen, S., and Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A., 74:5463-5467.
53. Sparks, R.L., and Scott, R.E. (1986) Transforming growth factor type β is a specific inhibitor of 3T3 T mesenchymal stem cell differentiation. Exp. Cell Res., 165:345-352.
54. Sparks, R.L., Allen, B.J., and Strauss, E.E. (1992) TGF-β blocks early but not late differentiation-specific gene expression and morphologic differentiation of 3T3 T proadipocytes. J. Cell. Physiol., 150:568-577.
55. Suzuki, A., Thies, R.S., Yamaji, N., Song, J.J., Wozney, J.M., Murakami, K., and Ueno, N. (1994) A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo. Proc. Natl. Acad. Sci. U.S.A., 97:10255-10259.
56. Tam, J.P., and Shao, J. (1994) Synthesis and use of multiple antigen peptide (MAP) systems. In Current protocols in immunology, edit. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, eds., John Wiley & Sons, New York, pp. 9.6.1-9.6.19.
57. Thies, R.S., Bauday, M., Ashton, B.A., Kurtzberg, L., Wozney, J.M., and Rosen, V. (1992) Recombinant bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology, 130:1318-1324.
58. Thomas, P.S. (1980) Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. U.S.A., 77:5201-5205.
59. Urist, M.R. (1965) Bone: Formation by autoinduction. Science, 150:863-869.
60. Ventura, F., Doody, J., Liu, F., Wrana, J.L., and Massague, J. (1994) Reconstitution and transphophorylation of TGFβ receptor complexes. EMBO J, 13:5581-5589.
61. Vukicevic, S., Luyten, F.P., and Reddi, A.H. (1989) Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc. Natl. Acad. Sci. U.S.A., 86:8793-8797.
62. Wozney, J.M. (1992) The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev., 32:160-167.
63. Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M., and Wang, E.A. (1988) Novel regulators of bone formation: Molecular clones and activities. Science, 242:1528-1534.
64. Wrana, J.L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. (1994) Mechanism of activation of the TGF-β receptor. Nature, 370:341-347.
65. 1 by a rat anti-stromal cell monoclonal antibody. Hybridoma, 13:409-416.
66. Wu, X., Robinson, C.E., Fong, H.W., Crabtree, J.S., Rodriguez, B.R., Roe, B.A., and Gimble, J.M. (1995) Cloning and characterization of the murine activin receptor like kinase-1 (ALK-1) homolog. Biochem. Biophys. Res. Commun., 216:78-83.
67. Yamaguchi, A., Katagiri, T., Ikeda, T., Wozney, J.M., Rosen, V., Wang, E.A., Kahn, A.J., Suda, T., and Yoshiki, S. (1991) Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol., 113:681-687.